Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
HoldingsOnline